z-logo
open-access-imgOpen Access
Phytochemicals and Bioactivities of Syzygium filiformevar. filiforme
Author(s) -
Mohd Hafiz Ahmad,
Norhazaor Izan,
Nor Hadiani Ismail,
Humera Naz
Publication year - 2021
Publication title -
sains malaysiana
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.251
H-Index - 29
ISSN - 0126-6039
DOI - 10.17576/jsm-2021-5011-07
Subject(s) - stigmasterol , ursolic acid , phytochemical , dpph , chemistry , betulinic acid , antibacterial activity , syzygium , minimum inhibitory concentration , terpene , bark (sound) , traditional medicine , bacteria , antioxidant , biochemistry , organic chemistry , chromatography , biology , antimicrobial , medicine , ecology , genetics
Syzygium filiforme var. filiforme is a plant variety from dicotyledonous plant family (Myrtaceae). Phytochemical studies on S. filiforme var. filiforme stem bark have successfully isolated and characterized arjunolic acid (1), alphitolic acid (2), betulinic acid (3), ursolic acid (4), ursolic acid 3-methyl ester (5), β-sitosterol (6) and stigmasterol (7). The inhibitory activities against free radical, starch, and bacteria for major compounds were tested by using DPPH, α-glucosidase and minimum inhibitory and bacterial concentration assays, respectively. No promising antioxidant activity was shown on tested samples except methanolic crude extract. For antidiabetic activity, methanolic and dichloromethane crude extracts displayed potent activity compared to 1-deoxynojirimycin. Minimum inhibitory concentration (MIC) and minimum bacterial concentration (MBC) assays for antibacterial activity were evaluated on Escherichia coli, Staphylococcus aureus, and Bacillus subtilis. All crude extracts and major compounds displayed weak and no promising activities for MIC method, respectively. Meanwhile, for MBC method, hexane crude extract and compound 1 showed inhibition against B. subtilis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here